Global Pharmaceutical Giants are optimistic about the new business opportunities of the Asian pharmaceutical market
Release time: 2010-12-20 & nbsp & nbsp & nbsp Source:
Business Club, December 20th Western Pharmaceutical Giants are launching a new round of fierce attacks to the rapidly growing Asian market: more common medicines for diseases in Asia。
Pfizer Inc.，Abbreviation: Pfizer) In the past year, it has been committed to the development of an anti -inflammatory drug in China in China，Liver disease is a big killer that endangers Asian life and health。Pfizer is the largest pharmaceutical company in the world based on sales。Johnson &Johnson) Last month, it announced cooperation with a university in Beijing，Research on a number of infectious diseases that threaten Asia。Bristol-Myers Squibb Co., a US Pharmaceutical Company, also announced last month that it cooperated with the headquarters of Simcere Pharmaceutical Group，jointly developing a treatment method against cancer。
Western pharmaceutical giants focusing on Asia'Stake Sports Bettings stake betting appstrategy marks the history of the pharmaceutical industry for the development of medicine for Western patients.。Although multinational pharmaceutical vendors may still study experimental medicines for experimental objects in Asia，But they will get the clinical trial results to the European and American markets to obtain the approval of regulatory agencies。
Western pharmaceutical vendors often bypassed the medical history of Asia in the past。In view of the environment、Genetics and some behavior habits，Liver disease、Some cancers and some infectious diseases are more common in Asian countries such as China and Thailand。
Pharmaceutical Company is currently pouring into the Asian market，Its purpose is to use the high growth of Asia to help the company respond to the price pressure and product aging in the European and American markets。The number of Asians who can afford Western medicines now are very crowded，and the number of people is still growing。Analyst David Maris, an analyst at Lyon Securities (CLSA)，The total value of prescription drugs sold in China is about 40 billion US dollars，and the Chinese market grows rapidly at a rate of about 25%each year，And the annual growth rate of the medical market in the United States and Europe is only 2%to 5%。Lyon Securities Headquarters is located in Hong Kong，Is an investment group focusing on Asian business。
Consider the market size of Asia，More pharmaceutical executives have begun to regard specific medical needs in Asia as their potential source of profit。Data of Lyon Securities，European and American pharmacists have invested more than $ 1 billion in the past year，Specially used to cultivate drug research and development and manufacturing capabilities in Asia。
There are more investment rolling。Bayer My stake betting appAG My stake betting appannounced the layoffs last month.，I hope to use the cost saved by layoffs to expand Asia's business capabilities，Including an increase in an emerging market 2,500 positions。
Pfizer established a research institute in Shanghai five years ago，Established an expert team composed of doctors and scholars，Provide help for the clinical needs of local patients。This company headquartered in New York saw the business opportunity brought by anti -inflammatory drugs，Hope brings hope for the treatment of liver disease due to anti -inflammatory drugs。Liver disease can deteriorate with the infection of hepatitis B virus，The incidence of hepatitis B is more common in Asian countries than the West。According to statistics from the World Health Organization，China and other Asian countries 40 -year -old people，70%to 90%infected hepatitis B virus，and North America and Western European countries only less than 20%。
The cooperation between Johnson & Johnson and Tsinghua University is an example of drug research and development cooperation。The goal of the initial laboratory work of the project is to understand hepatitis B more deeply、Diseases such as tuberculosis and bird flu，Preparation for the development of new treatment methods。There are many research centers in Tsinghua University，Google (Google) and Microsoft, such as American technology giants, are located around Tsinghua。
Starting from 2008，Johnson & Johnson began cooperation with Tianjin Medical University，Study the treatment of common cancers such as head and neck cancer。
Tianjin Medical University is located at 80 miles southwest of Beijing，With about 2,000 cancer hospital beds，Collect tumor tissue and blood cells from each Stake Sports Bettingpatient。stake betting appWilliam Hait, head of Johnson & Johnson Oncology Department, said，Johnson & Johnson hopes to confirm different biomarkers by cooperation with this university，For example, gene or protein，So which drugs are most effective for cancer patients。
Johnson & Johnson helps to train local researchers how to conduct detailed genes and analysis research，Because they are not enough to master these technologies。He said，Training time is longer than expected，But the research project has been started and is underway。
Bristol-Myers adopted different strategies，Authorized a Chinese company to develop a type of gastric cancer、Drug recipes for esophageal cancer and lung cancer。
This New York pharmaceutical company believes that local companies are better to do it，Therefore, the development and marketing right of the drug in China was sold。According to the authorization clause，Xianmin Pharmaceutical will be responsible for the management and funding support of research during the entire mid -term human test。
Jeremy Levin said，Although this may mean abandoning the short -term benefits of selling any related products in China，But Belky Schimi Bao can learn long -term experience from middle school; we are learning experience from other companies in other countries。
All drugs for epidemic diseases for Asian will still take years to develop。SATI SIAN, general manager of China Health (IMS Health), the medical industry consulting institution, said，but，Study these drugs can generate instant benefits，The attention of the demand for local pharmaceuticals will make Asian patients and the government a good impression of the company。
However, the company may be questioned by patients.
Mr. Chi, a 48 -year -old Beijing stake online sports bettingresident, stake betting appsaid，Western pharmaceutical companies to develop more new drugs are good，But he does not like these companies to concentrate on the more common disease treatment in Asia to sell these medicines to the Chinese。Mr. Chi, who is a property manager, said，I want to know why your companies don’t let people in their own country use these medicines。
Mr. Chi waited for a doctor on Monday because of gastrointestinal discomfort，He generally prefer to "condition" physical function with traditional Chinese medicine，For example, sleep problem, etc.，Because Chinese medicine is made of natural ingredients，Side effects less than western medicine。
Pfizer Inc.，Abbreviation: Pfizer) In the past year, it has been committed to the development of an anti -inflammatory drug in China in China，Liver disease is a big killer that endangers Asian life and health。Pfizer is the largest pharmaceutical company in the world based on sales。Johnson &Johnson) Last month, it announced cooperation with a university in Beijing，Research on a number of infectious diseases that threaten Asia。Bristol-Myers Squibb Co., a US Pharmaceutical Company, also announced last month that it cooperated with the headquarters of Simcere Pharmaceutical Group，jointly developing a treatment method against cancer。
Western pharmaceutical giants focusing on Asia'Stake Sports Bettings stake betting appstrategy marks the history of the pharmaceutical industry for the development of medicine for Western patients.。Although multinational pharmaceutical vendors may still study experimental medicines for experimental objects in Asia，But they will get the clinical trial results to the European and American markets to obtain the approval of regulatory agencies。
Western pharmaceutical vendors often bypassed the medical history of Asia in the past。In view of the environment、Genetics and some behavior habits，Liver disease、Some cancers and some infectious diseases are more common in Asian countries such as China and Thailand。
Pharmaceutical Company is currently pouring into the Asian market，Its purpose is to use the high growth of Asia to help the company respond to the price pressure and product aging in the European and American markets。The number of Asians who can afford Western medicines now are very crowded，and the number of people is still growing。Analyst David Maris, an analyst at Lyon Securities (CLSA)，The total value of prescription drugs sold in China is about 40 billion US dollars，and the Chinese market grows rapidly at a rate of about 25%each year，And the annual growth rate of the medical market in the United States and Europe is only 2%to 5%。Lyon Securities Headquarters is located in Hong Kong，Is an investment group focusing on Asian business。
Consider the market size of Asia，More pharmaceutical executives have begun to regard specific medical needs in Asia as their potential source of profit。Data of Lyon Securities，European and American pharmacists have invested more than $ 1 billion in the past year，Specially used to cultivate drug research and development and manufacturing capabilities in Asia。
There are more investment rolling。Bayer My stake betting appAG My stake betting appannounced the layoffs last month.，I hope to use the cost saved by layoffs to expand Asia's business capabilities，Including an increase in an emerging market 2,500 positions。
Pfizer established a research institute in Shanghai five years ago，Established an expert team composed of doctors and scholars，Provide help for the clinical needs of local patients。This company headquartered in New York saw the business opportunity brought by anti -inflammatory drugs，Hope brings hope for the treatment of liver disease due to anti -inflammatory drugs。Liver disease can deteriorate with the infection of hepatitis B virus，The incidence of hepatitis B is more common in Asian countries than the West。According to statistics from the World Health Organization，China and other Asian countries 40 -year -old people，70%to 90%infected hepatitis B virus，and North America and Western European countries only less than 20%。
The cooperation between Johnson & Johnson and Tsinghua University is an example of drug research and development cooperation。The goal of the initial laboratory work of the project is to understand hepatitis B more deeply、Diseases such as tuberculosis and bird flu，Preparation for the development of new treatment methods。There are many research centers in Tsinghua University，Google (Google) and Microsoft, such as American technology giants, are located around Tsinghua。
Starting from 2008，Johnson & Johnson began cooperation with Tianjin Medical University，Study the treatment of common cancers such as head and neck cancer。
Tianjin Medical University is located at 80 miles southwest of Beijing，With about 2,000 cancer hospital beds，Collect tumor tissue and blood cells from each Stake Sports Bettingpatient。stake betting appWilliam Hait, head of Johnson & Johnson Oncology Department, said，Johnson & Johnson hopes to confirm different biomarkers by cooperation with this university，For example, gene or protein，So which drugs are most effective for cancer patients。
Johnson & Johnson helps to train local researchers how to conduct detailed genes and analysis research，Because they are not enough to master these technologies。He said，Training time is longer than expected，But the research project has been started and is underway。
Bristol-Myers adopted different strategies，Authorized a Chinese company to develop a type of gastric cancer、Drug recipes for esophageal cancer and lung cancer。
This New York pharmaceutical company believes that local companies are better to do it，Therefore, the development and marketing right of the drug in China was sold。According to the authorization clause，Xianmin Pharmaceutical will be responsible for the management and funding support of research during the entire mid -term human test。
Jeremy Levin said，Although this may mean abandoning the short -term benefits of selling any related products in China，But Belky Schimi Bao can learn long -term experience from middle school; we are learning experience from other companies in other countries。
All drugs for epidemic diseases for Asian will still take years to develop。SATI SIAN, general manager of China Health (IMS Health), the medical industry consulting institution, said，but，Study these drugs can generate instant benefits，The attention of the demand for local pharmaceuticals will make Asian patients and the government a good impression of the company。
However, the company may be questioned by patients.
Mr. Chi, a 48 -year -old Beijing stake online sports bettingresident, stake betting appsaid，Western pharmaceutical companies to develop more new drugs are good，But he does not like these companies to concentrate on the more common disease treatment in Asia to sell these medicines to the Chinese。Mr. Chi, who is a property manager, said，I want to know why your companies don’t let people in their own country use these medicines。
Mr. Chi waited for a doctor on Monday because of gastrointestinal discomfort，He generally prefer to "condition" physical function with traditional Chinese medicine，For example, sleep problem, etc.，Because Chinese medicine is made of natural ingredients，Side effects less than western medicine。
